Top 200 Drugs Study Guide

Top 200 drugs

Top 200 Drugs Study Guide Summary

For the PTCE, focus on each drug’s brand and generic namestherapeutic classprimary indication, and a red‑flag adverse effect/contraindication. Use the suffix cheat sheet and the tables below to study faster and spend more time on the rest of the exam.

Disclaimer: This post is informational only and intended to guide students in studying for the PTCE. It is not meant to represent comprehensive drug information and should not be used as a reference for patient care or decision-making.


On this page


What the “Top 200 drugs” means for the PTCE

The Top 200 drugs are the most commonly prescribed outpatient medications in the U.S. There is no single “official” PTCB list. This study convention is drawn from prescribing data and teaching curricula. For the exam, you should be comfortable with each drug’s brand and generic namesclassprimary use, and one or two high-yield adverse effects/contraindications. Verify clinical specifics in label sources like DailyMed or FDALabel.

PTCE exam weight: how many medication questions?

Through 2025, the Medications domain is 40% of the PTCE.
Effective January 2026: it becomes 35% with small shifts across other domains. Medications remain the most significant single portion of the exam. See the PTCB content outlines: current guidebook and effective‑Jan‑2026 PDF.

How to memorize the Top 200 (step‑by‑step)

  1. Group by class. Learn common effects and uses once; apply to all members.
  2. Learn the suffix patterns. E.g., –pril (ACE inhibitors), –sartan (ARBs), –olol (β‑blockers), –statin (statins).
  3. Drill brand and generic names daily. Use spaced‑repetition flashcards and mix look-alike/sound-alike pairs.
  4. Attach one primary use + one red‑flag effect to each drug as you go.
  5. Spiral review. Re-test older material at increasing intervals; shuffle classes.

Tip: Keep your flashcards in a 3-column format—Brand → Generic → Class—to speed class recognition during the exam.

Suffix cheat sheet

SuffixClassCommon examplesPrimary useRed‑flag effect
‑prilACE inhibitorslisinoprilHTN/HFcough, hyperkalemia
‑sartanARBslosartan, valsartanHTN/HFhyperkalemia
‑ololβ‑blockersmetoprolol, atenololHTN/angina/HFbradycardia
‑dipineDHP CCBsamlodipine, nifedipineHTNedema
‑statinHMG‑CoA reductase inhibitorsatorvastatin, rosuvastatinhyperlipidemiamyopathy
‑prazolePPIsomeprazole, pantoprazoleGERD↓Mg, infection risk (long‑term)
‑tidineH2 blockersfamotidineGERDconfusion (elderly)
‑gliptinDPP‑4 inhibitorssitagliptinT2DMnasopharyngitis
‑gliflozinSGLT2 inhibitorsempagliflozinT2DM/HFgenital infections
‑cillinPenicillinsamoxicillininfectionsallergy/rash
‑floxacinFluoroquinolonesciprofloxacin, levofloxacininfectionstendon rupture
‑azoleAzole antifungalsfluconazolefungal infectionshepatotoxicity
‑zosinα1‑blockerstamsulosinBPHorthostasis
‑oxetine / ‑pramSSRIsfluoxetine, citalopramdepression/anxietysexual dysfunction

Quick‑study tables: brand↔generic, class, primary use, key effect

The entries below cover the most frequently tested classes. Use them to build your deck. For complete clinical information, check labels on DailyMed or FDALabel. For macro context, see the University of Arizona’s annual Top 200 posters.

Cardiovascular (hypertension, lipids, heart failure)

BrandGenericClassPrimary useKey red‑flag
Zestril / PrinivillisinoprilACE inhibitorHTN/HFcough, hyperkalemia
CozaarlosartanARBHTN/HFhyperkalemia
DiovanvalsartanARBHTN/HFhyperkalemia
NorvascamlodipineDHP CCBHTNedema
Toprol‑XL / Lopressormetoprololβ‑blockerHTN/angina/HFbradycardia
Tenorminatenololβ‑blockerHTNbradycardia
Coregcarvedilolβ‑blockerHF/HTNdizziness
Microzidehydrochlorothiazidethiazide diureticHTNhypokalemia
Lasixfurosemideloop diureticedema/HFhypokalemia, ototoxicity
AldactonespironolactoneK‑sparing diureticHF/HTNhyperkalemia, gynecomastia
Lipitoratorvastatinstatinhyperlipidemiamyopathy
Crestorrosuvastatinstatinhyperlipidemiamyopathy
Zocorsimvastatinstatinhyperlipidemiamyopathy
PlavixclopidogrelantiplateletASCVDbleeding
EliquisapixabanAnticoagulantAF/VTEbleeding
XareltorivaroxabanAnticoagulantAF/VTEbleeding
CoumadinwarfarinAnticoagulantAF/VTEbleeding; many interactions

Endocrine & metabolic

BrandGenericClassPrimary useKey red‑flag
GlucophagemetforminbiguanideDiabetesGI upset; rare lactic acidosis
AmarylglimepiridesulfonylureaDiabeteshypoglycemia
GlucotrolglipizidesulfonylureaDiabeteshypoglycemia
JardianceempagliflozinSGLT2 inhibitorDiabetesgenital infections
OzempicsemaglutideGLP‑1 RADiabetes/weight lossGI effects (class warning for thyroid C‑cell tumors)
Lantusinsulin glarginebasal insulinDiabeteshypoglycemia
Humaloginsulin lisprorapid insulinDiabeteshypoglycemia
Levemirinsulin detemirbasal insulinDiabeteshypoglycemia
Synthroidlevothyroxinethyroid hormonehypothyroidismover‑replacement → palpitations
Zyloprimallopurinolxanthine oxidase inhibitorgoutrash (SJS/TEN)
Uloricfebuxostatxanthine oxidase inhibitorgoutCV risk warning

CNS & psychiatric

BrandGenericClassPrimary useKey red‑flag
ZoloftsertralineSSRIdepression/anxietysexual dysfunction
LexaproescitalopramSSRIdepression/anxietyQT risk at high dose
ProzacfluoxetineSSRIdepressionactivating/insomnia
CymbaltaduloxetineSNRIdepression/neuropathic pain↑BP
Effexor XRvenlafaxineSNRIdepression/anxiety↑BP, withdrawal
ElavilamitriptylineTCAneuropathic painanticholinergic effects
Wellbutrin SR/XLbupropionNDRIdepression/smokingseizures (dose-related)
Xanaxalprazolambenzodiazepineanxietysedation, dependence
Ativanlorazepambenzodiazepineanxietysedation
Ambienzolpidemhypnoticinsomniacomplex sleep behaviors
Seroquelquetiapineatypical antipsychoticschizophreniametabolic effects
Risperdalrisperidoneatypical antipsychoticschizophreniahyperprolactinemia
Ariceptdonepezilacetylcholinesterase inhibitorAlzheimer’sbradycardia, GI

Respiratory & allergy

BrandGenericClassPrimary useKey red‑flag
ProAir / Proventil / VentolinalbuterolSABAasthmatachycardia
Advairfluticasone/salmeterolICS/LABAasthma/COPDoral thrush (rinse)
Symbicortbudesonide/formoterolICS/LABAasthma/COPDoral thrush (rinse)
SpirivatiotropiumLAMACOPDdry mouth
Singulairmontelukastleukotriene antagonistasthma/allergyneuropsychiatric warnings
Flonasefluticasone (intranasal)corticosteroidallergic rhinitisepistaxis
Claritinloratadine2nd‑gen antihistamineallergyminimal sedation
Zyrteccetirizine2nd‑gen antihistamineallergydrowsiness (some)

Anti‑infectives

BrandGenericClassPrimary useKey red‑flag
Amoxilamoxicillinpenicillinbacterial infectionsrash/allergy
Augmentinamoxicillin/clavulanatepenicillin + β-lactamase inhibitorbacterial infectionsGI upset
Keflexcephalexin1st‑gen cephalosporinbacterial infectionscross‑allergy (PCN)
Omnicefcefdinir3rd‑gen cephalosporinbacterial infectionsdiarrhea
Zithromaxazithromycinmacrolidebacterial infectionsQT prolongation
Levaquinlevofloxacinfluoroquinolonebacterial infectionstendon rupture
Ciprociprofloxacinfluoroquinolonebacterial infectionstendon rupture
Vibramycindoxycyclinetetracyclinebacterial infections/ acnephotosensitivity; separate from cations
Bactrim / Septrasulfamethoxazole/trimethoprimsulfonamidebacterial infectionsrash, hyperkalemia
Flagylmetronidazolenitroimidazolebacterial infectionsAvoid alcohol (disulfiram‑like)
Macrobidnitrofurantoinurinary antisepticUTIrare pulmonary/hepatic toxicity
Diflucanfluconazoleazole antifungalFungal infectionshepatotoxicity
ValtrexvalacyclovirantiviralHerpes / Shinglesrenal dosing

GI & other high‑yield

BrandGenericClassPrimary useKey red‑flag
PrilosecomeprazolePPIGERDlow Mg, fracture risk (long‑term)
ProtonixpantoprazolePPIGERDlow Mg
PepcidfamotidineH2 blockerGERDconfusion (elderly)
Zofranondansetron5‑HT3 antagonistN/VQT prolongation
ReglanmetoclopramideprokineticgastroparesisEPS/tardive dyskinesia
Colacedocusatestool softenerconstipationcramping
MiraLAXpolyethylene glycolosmotic laxativeconstipationdiarrhea
Fosamaxalendronatebisphosphonateosteoporosisesophagitis (empty stomach; upright)
Flomaxtamsulosinα1‑blockerBPHorthostasis
Proscarfinasteride5‑α‑reductase inhibitorBPHteratogenic; avoid handling in pregnancy
DitropanoxybutyninantimuscarinicOABdry mouth, constipation
(no brand)prednisonecorticosteroidinflammationhyperglycemia, infection risk
Medrolmethylprednisolonecorticosteroidinflammationclass effects
Neurontingabapentinanticonvulsantneuropathic paindizziness/sedation
Tylenolacetaminophenanalgesicpain/feverhepatotoxicity (dose limits)
Motrin / AdvilibuprofenNSAIDpainGI bleed, renal risk
Naprosyn / AlevenaproxenNSAIDpainGI bleed, renal risk
Norco / Vicodinhydrocodone/acetaminophenopioid combopainsedation, constipation
Percocetoxycodone/acetaminophenopioid combopainsedation, constipation
Narcannaloxoneopioid antagonistoverdoseacute withdrawal

Note: Some legacy brand names are no longer marketed but still appear in study resources: know the mapping.

Class‑by‑class overview: what each group treats (+ gotchas)

  • ACE inhibitors (‑pril): HTN/HF/nephroprotection; avoid in pregnancy; monitor K⁺.
  • ARBs (‑sartan): HTN/HF; avoid in pregnancy; monitor K⁺.
  • DHP CCBs (‑dipine): HTN; edema; possible gingival hyperplasia.
  • β‑blockers (‑olol): HTN/angina/AF/HF; bradycardia; avoid abrupt stop.
  • Thiazides: HTN; hypokalemia; photosensitivity.
  • Loops: edema/HF; hypokalemia; ototoxicity (high dose/rapid IV).
  • Statins (‑statin): dyslipidemia; myopathy; avoid in pregnancy.
  • Sulfonylureas: T2DM; hypoglycemia; weight gain.
  • SGLT2 inhibitors (‑gliflozin): T2DM/HF; genital infections; volume depletion.
  • GLP‑1 RAs: T2DM/weight; GI effects; class boxed warning for thyroid C‑cell tumors.
  • SSRIs/SNRIs: depression/anxiety; sexual dysfunction (SSRIs), ↑BP (SNRIs).
  • Atypical antipsychotics: schizophrenia/bipolar; metabolic effects.
  • Opioids: sedation, constipation, respiratory depression; combine with naloxone education.
  • Macrolides: QT risk; CYP interactions.
  • Fluoroquinolones: tendinopathy, QT risk; reserve when appropriate.
  • Tetracyclines: photosensitivity; separate from cations.
  • PPIs: infection/nutrient effects with long-term use.

High-risk side effects & interactions to know cold

  • Anticoagulants/antiplatelets (warfarin, DOACs, clopidogrel) → bleeding risks
  • Insulins & sulfonylureas → hypoglycemia
  • ACEi/ARB/K‑sparing diuretics → hyperkalemia 
  • Fluoroquinolones, macrolides, ondansetron → QT prolongation.
  • Metronidazole + alcohol → disulfiram‑like reaction 
  • Statins + strong CYP inhibitors → myopathy risk.
  • Benzodiazepines + opioids → additive respiratory depression.

Mini Top 200 Drugs self-test: 10 quick questions

Loading question…

FAQs

What is the best way to memorize the Top 200 drugs?

Break the list into classes, memorize suffixes, and drill brand↔generic with spaced‑repetition flashcards. Tie one primary use and one red‑flag effect to each drug. Practice daily in 10–15 minute sets.

Do I need to memorize both brand and generic names?

Yes. Brand↔generic matching is frequently tested and speeds up class-based questions that reference only one of the two.

How many drugs are on the PTCE?

There isn’t an official list; “Top 200” is a study convention. Expect many medication questions—Medications are 40% through 2025 and 35% beginning January 2026. See PTCB’s outline and the 2026 outline.

Which suffixes should I know first?

Start with –pril (ACEi), –sartan (ARB), –olol (β‑blocker), –dipine (DHP CCB), –statin (statins), –prazole (PPIs), –gliflozin (SGLT2), –gliptin (DPP‑4), –cillin (penicillins), –floxacin (FQs).

Are posters helpful study aids?

Yes. The University of Arizona’s Njardarson Lab publishes free Top 200 posters (by sales or prescriptions). They’re great for context alongside your flashcards.

Resources

Abbreviations Used in this Guide

AbbreviationMeaning
5‑HT35‑hydroxytryptamine (serotonin) type‑3 receptor
ACEiAngiotensin‑converting enzyme inhibitor
AFAtrial fibrillation
ARBAngiotensin II receptor blocker
ASCVDAtherosclerotic cardiovascular disease
BPHBenign prostatic hyperplasia
BPBlood pressure
CCBCalcium channel blocker
C. difficileClostridioides difficile (bacterium that can cause severe diarrhea)
COPDChronic obstructive pulmonary disease
CVCardiovascular
CYPCytochrome P450 drug‑metabolizing enzyme system
DHPDihydropyridine (subclass of CCBs)
DOACDirect oral anticoagulant
DPP‑4Dipeptidyl peptidase‑4
EPSExtrapyramidal symptoms (movement‑related adverse effects)
GERDGastroesophageal reflux disease
GIGastrointestinal
GLP‑1 RAGlucagon‑like peptide‑1 receptor agonist
HFHeart failure
H2 (blocker)Histamine‑2 receptor antagonist
HTNHypertension
ICSInhaled corticosteroid
ICS/LABACombination of inhaled corticosteroid + long‑acting beta agonist
INRInternational Normalized Ratio (measure of blood coagulation)
K+Potassium (positively charged ion)
K‑sparingPotassium‑sparing (typically refers to diuretics)
LABALong‑acting beta agonist
LAMALong‑acting muscarinic antagonist
MgMagnesium
NDRINorepinephrine–dopamine reuptake inhibitor
N/VNausea and vomiting
NSAIDNonsteroidal anti‑inflammatory drug
OABOveractive bladder
PCNPenicillin
PPIProton pump inhibitor
PTCEPharmacy Technician Certification Exam
PTCBPharmacy Technician Certification Board
QT (prolongation)Heart’s QT interval (abnormal prolongation increases arrhythmia risk)
RAReceptor agonist (as in GLP‑1 RA)
SABAShort‑acting beta agonist
SGLT2Sodium‑glucose cotransporter 2
SJS/TENStevens‑Johnson syndrome / toxic epidermal necrolysis
SNRISerotonin–norepinephrine reuptake inhibitor
SRSustained‑release (dosage form)
SSRISelective serotonin reuptake inhibitor
T1DMType 1 diabetes mellitus
T2DMType 2 diabetes mellitus
TCATricyclic antidepressant
U.S.United States
UTIUrinary tract infection
VKAVitamin K antagonist
VTEVenous thromboembolism
VZVVaricella‑zoster virus
HSVHerpes simplex virus
XRExtended‑release (dosage form)
XLExtended‑release (dosage form)
β‑blockerBeta‑adrenergic receptor blocker
β1Beta‑1 (cardioselective) subtype
α1Alpha‑1 adrenergic receptor

Symbols Used

  •  = increase;  = decrease
  • / = combination (e.g., AF/VTE; ICS/LABA)
  •  = “leads to” or “results in” (used in side‑effect callouts)

Share Post:

Join Our Newsletter

Sign In (Legacy)

Use this sign in if you enrolled before May 27, 2025 and have not moved to our new program 

Sign In (New)

Use this sign in if you are a learner on our new platform. This will be all students who migrated or joined after May 26.

Privacy Settings